SE438858B - Halogenerade 15-hydroxi-e-homoeburnanderivat och forfarande for deras framstellning - Google Patents

Halogenerade 15-hydroxi-e-homoeburnanderivat och forfarande for deras framstellning

Info

Publication number: SE438858B
Authority: SE; Sweden
Prior art keywords: acid; hydroxy; acid addition; mixture; optically active
Prior art date: 1979-08-06

Application number

SE8005560A

Other languages

English (en)

Swedish (sv)

Other versions

SE8005560L (sv

Inventor

C Szantay

L Szabo

G Kalaus

L Dancsi

T Keve

F Draxler

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-08-06

Filing date

1980-08-05

Publication date

1985-05-13

1980-08-05 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

1981-02-07 Publication of SE8005560L publication Critical patent/SE8005560L/xx

1985-05-13 Publication of SE438858B publication Critical patent/SE438858B/sv

Links

238000000034 method Methods 0.000 title claims description 7
239000000203 mixture Substances 0.000 title description 19
238000002360 preparation method Methods 0.000 title description 2
150000001875 compounds Chemical class 0.000 claims description 20
239000002253 acid Chemical group 0.000 claims description 17
150000003839 salts Chemical class 0.000 claims description 9
238000006243 chemical reaction Methods 0.000 claims description 7
229910052736 halogen Inorganic materials 0.000 claims description 4
125000000217 alkyl group Chemical group 0.000 claims description 3
125000004432 carbon atom Chemical group C* 0.000 claims description 3
150000002367 halogens Chemical class 0.000 claims description 3
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 claims description 2
239000002841 Lewis acid Substances 0.000 claims description 2
150000007517 lewis acids Chemical class 0.000 claims description 2
239000003795 chemical substances by application Substances 0.000 claims 1
238000003776 cleavage reaction Methods 0.000 claims 1
125000005843 halogen group Chemical group 0.000 claims 1
230000002140 halogenating effect Effects 0.000 claims 1
230000026030 halogenation Effects 0.000 claims 1
238000005658 halogenation reaction Methods 0.000 claims 1
238000004519 manufacturing process Methods 0.000 claims 1
230000007017 scission Effects 0.000 claims 1
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 12
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
239000000243 solution Substances 0.000 description 9
239000002904 solvent Substances 0.000 description 9
239000000126 substance Substances 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 7
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
229960000583 acetic acid Drugs 0.000 description 7
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 7
229910052794 bromium Inorganic materials 0.000 description 7
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
229910021529 ammonia Inorganic materials 0.000 description 6
239000007864 aqueous solution Substances 0.000 description 6
239000012362 glacial acetic acid Substances 0.000 description 6
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
150000007513 acids Chemical class 0.000 description 5
238000002329 infrared spectrum Methods 0.000 description 5
238000002844 melting Methods 0.000 description 5
230000008018 melting Effects 0.000 description 5
239000000047 product Substances 0.000 description 5
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
239000012071 phase Substances 0.000 description 4
239000000741 silica gel Substances 0.000 description 4
229910002027 silica gel Inorganic materials 0.000 description 4
239000007858 starting material Substances 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
239000003463 adsorbent Substances 0.000 description 3
239000008346 aqueous phase Substances 0.000 description 3
230000031709 bromination Effects 0.000 description 3
238000005893 bromination reaction Methods 0.000 description 3
229940044631 ferric chloride hexahydrate Drugs 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 3
238000001819 mass spectrum Methods 0.000 description 3
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
238000012746 preparative thin layer chromatography Methods 0.000 description 3
239000007787 solid Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000002425 crystallisation Methods 0.000 description 2
230000008025 crystallization Effects 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
235000019341 magnesium sulphate Nutrition 0.000 description 2
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
239000011976 maleic acid Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
239000003495 polar organic solvent Substances 0.000 description 2
235000019260 propionic acid Nutrition 0.000 description 2
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
229910015900 BF3 Inorganic materials 0.000 description 1
239000005711 Benzoic acid Substances 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 1
229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229960004050 aminobenzoic acid Drugs 0.000 description 1
229960004909 aminosalicylic acid Drugs 0.000 description 1
229910052787 antimony Inorganic materials 0.000 description 1
WATWJIUSRGPENY-UHFFFAOYSA-N antimony atom Chemical compound [Sb] WATWJIUSRGPENY-UHFFFAOYSA-N 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
235000010233 benzoic acid Nutrition 0.000 description 1
229960004365 benzoic acid Drugs 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
125000001246 bromo group Chemical group Br* 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
235000013985 cinnamic acid Nutrition 0.000 description 1
229930016911 cinnamic acid Natural products 0.000 description 1
239000003480 eluent Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
229940032296 ferric chloride Drugs 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
-1 hydrogen halides Chemical class 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
238000000746 purification Methods 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000011877 solvent mixture Substances 0.000 description 1
239000001119 stannous chloride Substances 0.000 description 1
235000011150 stannous chloride Nutrition 0.000 description 1
239000000725 suspension Substances 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
108010072897 transcription factor Brn-2 Proteins 0.000 description 1
239000011592 zinc chloride Substances 0.000 description 1
235000005074 zinc chloride Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SE8005560A 1979-08-06 1980-08-05 Halogenerade 15-hydroxi-e-homoeburnanderivat och forfarande for deras framstellning SE438858B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU79RI721A HU180928B (en)	1979-08-06	1979-08-06	Process for preparing new brominated 15-hydroxy-e-homo-eburane derivatives

Publications (2)

Publication Number	Publication Date
SE8005560L SE8005560L (sv)	1981-02-07
SE438858B true SE438858B (sv)	1985-05-13

Family

ID=11001104

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8005560A SE438858B (sv)	1979-08-06	1980-08-05	Halogenerade 15-hydroxi-e-homoeburnanderivat och forfarande for deras framstellning

Country Status (22)

Country	Link
US (2)	US4285865A (fr)
JP (1)	JPS5636488A (fr)
AT (1)	AT375080B (fr)
AU (1)	AU534494B2 (fr)
BE (1)	BE884567A (fr)
CA (1)	CA1137473A (fr)
CH (1)	CH647779A5 (fr)
DE (1)	DE3026601A1 (fr)
DK (1)	DK337180A (fr)
ES (1)	ES494034A0 (fr)
FI (1)	FI70021C (fr)
GB (1)	GB2058756B (fr)
HU (1)	HU180928B (fr)
IL (1)	IL60587A (fr)
IT (1)	IT1132533B (fr)
NL (1)	NL8004350A (fr)
NO (1)	NO802345L (fr)
NZ (1)	NZ194571A (fr)
PH (1)	PH15612A (fr)
SE (1)	SE438858B (fr)
SU (1)	SU931107A3 (fr)
ZA (1)	ZA804302B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU180927B (en) *	1979-07-13	1983-05-30	Richter Gedeon Vegyeszet	Process for producing 1k-hydroximino-e-homoe-eburane de rivatives
HU180929B (en) *	1979-08-13	1983-05-30	Richter Gedeon Vegyeszet	Process for producing new bromo-vincamone derivatives
HU187139B (en) *	1982-06-30	1985-11-28	Richter Gedeon Vegyeszet	Process for preparing new eburnan derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3770724A (en) *	1970-03-31	1973-11-06	Roussel Uclaf	Process for preparing pentacyclic alkaloids
FR2206090A1 (en) *	1972-11-16	1974-06-07	Omnium Chimique Sa	Homovincamone-contg. medicaments - with vasodilating, spasmolytic anti-arrhythmic and anti-ischaemic properties
SE422798B (sv) *	1973-12-18	1982-03-29	Sandoz Ag	Analogiforfarande for framstellning av vincaminderivat
GB2010833B (en) *	1977-11-25	1982-04-15	Scras	Homoerburnamine preparation
CH649295A5 (de) *	1978-07-12	1985-05-15	Richter Gedeon Vegyeszet	Optisch aktive oder razemische brom-e-homo-eburanderivate.

1979
- 1979-08-06 HU HU79RI721A patent/HU180928B/hu not_active IP Right Cessation
1980
- 1980-07-14 DE DE19803026601 patent/DE3026601A1/de not_active Withdrawn
- 1980-07-15 IL IL60587A patent/IL60587A/xx unknown
- 1980-07-16 ZA ZA00804302A patent/ZA804302B/xx unknown
- 1980-07-24 PH PH24345A patent/PH15612A/en unknown
- 1980-07-30 NL NL8004350A patent/NL8004350A/xx not_active Application Discontinuation
- 1980-07-31 BE BE1/9913A patent/BE884567A/fr not_active IP Right Cessation
- 1980-07-31 AT AT0396480A patent/AT375080B/de not_active IP Right Cessation
- 1980-08-01 FI FI802410A patent/FI70021C/fi not_active IP Right Cessation
- 1980-08-05 SU SU802954159A patent/SU931107A3/ru active
- 1980-08-05 SE SE8005560A patent/SE438858B/sv not_active IP Right Cessation
- 1980-08-05 NZ NZ194571A patent/NZ194571A/xx unknown
- 1980-08-05 IT IT24015/80A patent/IT1132533B/it active
- 1980-08-05 JP JP10684780A patent/JPS5636488A/ja active Pending
- 1980-08-05 AU AU61103/80A patent/AU534494B2/en not_active Ceased
- 1980-08-05 NO NO802345A patent/NO802345L/no unknown
- 1980-08-05 DK DK337180A patent/DK337180A/da not_active Application Discontinuation
- 1980-08-05 US US06/175,385 patent/US4285865A/en not_active Expired - Lifetime
- 1980-08-05 CH CH5922/80A patent/CH647779A5/de not_active IP Right Cessation
- 1980-08-06 ES ES494034A patent/ES494034A0/es active Granted
- 1980-08-06 CA CA000357709A patent/CA1137473A/fr not_active Expired
- 1980-08-06 GB GB8025577A patent/GB2058756B/en not_active Expired
- 1980-12-16 US US06/216,903 patent/US4343738A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU534494B2 (en)	1984-02-02
NL8004350A (nl)	1981-02-10
ZA804302B (en)	1981-09-30
US4343738A (en)	1982-08-10
IL60587A0 (en)	1980-09-16
NZ194571A (en)	1982-11-23
FI70021C (fi)	1986-09-12
NO802345L (no)	1981-02-09
CA1137473A (fr)	1982-12-14
ES8106526A1 (es)	1981-08-01
DE3026601A1 (de)	1981-02-26
GB2058756A (en)	1981-04-15
CH647779A5 (de)	1985-02-15
ES494034A0 (es)	1981-08-01
SE8005560L (sv)	1981-02-07
US4285865A (en)	1981-08-25
JPS5636488A (en)	1981-04-09
AT375080B (de)	1984-06-25
FI802410A7 (fi)	1981-02-07
DK337180A (da)	1981-02-07
ATA396480A (de)	1983-11-15
IL60587A (en)	1983-05-15
PH15612A (en)	1983-02-28
IT1132533B (it)	1986-07-02
IT8024015A0 (it)	1980-08-05
BE884567A (fr)	1981-02-02
HU180928B (en)	1983-05-30
GB2058756B (en)	1984-02-08
SU931107A3 (ru)	1982-05-23
AU6110380A (en)	1981-02-12
FI70021B (fi)	1986-01-31

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 8005560-1

Effective date: 19920306

Format of ref document f/p: F

Publication	Publication Date	Title
EP0161534B1 (fr)	1989-09-20	Procédé pour la synthèse de pyridoimidazo rifamycines
JPH0149271B2 (fr)	1989-10-24
HU206200B (en)	1992-09-28	Process for producing compounds comprising condensed quinoline ring system
US4283401A (en)	1981-08-11	Process for the preparation of 11-bromo-vincaminic acid ester derivatives and their use in protecting animals against cerebral hypoxy
HU176446B (en)	1981-03-28	Process for the reduction of cepham or cephem sulphoxides
JP6226363B2 (ja)	2017-11-08	ビス−ボロンジピロメテン系色素
US4285865A (en)	1981-08-25	Process for the preparation of halogenated 15-hydroxy-E-homoeburnane compounds
SE438504B (sv)	1985-04-22	15-halogen-e-homoeburnanderivat och forfarande for deras framstellning
KR870001922B1 (ko)	1987-10-22	이미다졸 유도체의 제조방법
SU1380612A3 (ru)	1988-03-07	Способ получени активного тиоэфира производных (Z)-2-(2-амино-4-тиазолил)-2-алкоксикарбонилалкоксииминоуксусной кислоты
HU193780B (en)	1987-11-30	Process for producing 2-halogeno-6-methyl-ergol-9-ene derivatives and acid additional salts thereof
CN107652338B (zh)	2021-02-26	糖偶联-1,2,3-三氮唑取代的多环芳烃衍生物在制备抗癌药物的用途
CS219347B2 (en)	1983-03-25	Method of preparation of the 1-hydroxyaporfin derivative
US20110015269A1 (en)	2011-01-20	Process for the preparation of diacerin
JP2608761B2 (ja)	1997-05-14	７−ブロモ−β−カルボリン誘導体の製造方法およびその中間体
FI64136B (fi)	1983-06-30	Foerfarande foer framstaellning av d-2-(6-metoxi-2-naftyl)-propionsyra
CN108484670B (zh)	2020-11-24	一种含磷苯并恶嗪酮类化合物的合成方法
Vandana et al.	2004	A facile synthesis of novel 2-acetyl-1-hydroxycarbazoles–synthesis of biogenetically possible 2-phenyl-4-oxopyrano [2, 3-a] carbazoles and annelated carbazoles
HU180930B (en)	1983-05-30	Process for producing ester-derivatives of halogenovincaminic acid
HU181484B (en)	1983-07-28	Process for preparing 11-bromo-15-hydroxyimino-e-homo-eburnane derivatives
JPH1045727A (ja)	1998-02-17	ピラジンジカルボン酸誘導体及びその製造方法
HU183886B (en)	1984-06-28	Process for producing 15-halogeno-e-homoeo-eburnane derivatives
JPH0812658A (ja)	1996-01-16	シドノン類の製造法
JPH02149582A (ja)	1990-06-08	６−アリールオキシ−１Ｈ−ピラゾロ〔１，５−ｂ〕−１，２，４−トリアゾール化合物
JPS6157829B2 (fr)	1986-12-09